Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
The Bamboo Works

Cancer Drug Maker BeiGene Takes Action to Mitigate Delisting Risk

Key Takeaways:

  • BeiGene has switched auditors for its New York listing to a U.S. company from a Chinese one in a move to comply with U.S. law
  • The change could reduce the company’s threat of being forcibly delisted from the Nasdaq
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.